Dr. Jason Loveridge
NON-EXECUTIVE DIRECTOR
Life Science
Actinogen
Australia
Biography
Dr Loveridge has been working in the biomedical technology industry for over 20 years and has extensive experience in developing clinical stage biotechnology companies. As a venture investor with JAFCO Nomura, Dr Loveridge participated and invested in the start-up of over 24 companies in Europe, the United States and Israel. Since 2005, he has been directly involved in senior management of a number of small innovative companies in the biomedical field, specifically in refinancing and product commercialisation. In addition to Actinogen Medical, Dr Loveridge is also a Non-Executive Director of Resonance Health (ASX: RHT) and CEO of German based biopharmaceutical company 4SC AG. Dr Loveridge holds a PhD in Biochemistry and is a fellow of the Royal Society of Medicine.
Research Interest
Biochemistry
